Namilumab or infliximab compared to standard of care in hospitalised patients with COVID-19 (CATALYST): a phase 2 randomised adaptive trial

Benjamin A. Fisher; Tonny Veenith; Daniel Slade; Charlotte Gaskell; Matthew Rowland; Tony Whitehouse; James Scriven; Dhruv Parekh; Madhu S. Balasubramaniam; Graham Cooke; Nick Morley; Zoe Gabriel; Matthew P. Wise; Joanna Porter; Helen McShane; Ling-Pei Ho; Philip N. Newsome; Anna Rowe; Rowena Sharpe; David R. Thickett; Julian Bion; Simon Gates; Duncan Richards; Pamela Kearns

bioRxiv (2021) - Comments
doi: 10.1101/2021.06.02.21258204

Benjamin A. Fisher, Tonny Veenith, Daniel Slade, Charlotte Gaskell, Matthew Rowland, Tony Whitehouse, James Scriven, Dhruv Parekh, Madhu S. Balasubramaniam, Graham Cooke, Nick Morley, Zoe Gabriel, Matthew P. Wise, Joanna Porter, Helen McShane, Ling-Pei Ho, Philip N. Newsome, Anna Rowe, Rowena Sharpe, David R. Thickett